Papers/PMID:33594986
The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.
Nutrition, metabolism, and cardiovascular diseases : NMCD2021The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
calciol — increases serum 25-hydroxyvitamin D concentration
PreliminaryGrade D, Preliminary. Non-human or in vitro only.Findingreplicated ×9“Cholecalciferol significantly increased serum levels of 25(OH)D and fetuin-A in the treatment group (p-value < 0.001), while no significant difference was observed in the placebo group.”
Quoted verbatim from The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.. - Study
- RCT
- Dose
- 200,000 IU cholecalciferol per month, oral, for 3 months
- Population
- Hemodialysis patients
The impact of cholecalciferol on markers of vascular calcification in hemodialysis patients: A randomized placebo controlled study.2021PMID:33594986